In this excerpt from the webinar, “Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, Implications” provides an overview of the EU and US regulations and guidance for how to conduct safety benefit-risk assessments. This excerpt is presented by Mary Mease, RPH, MPH, Senior Director of Benefit-Risk Management at Quintiles.

To see our full webinar, please click here.